JY
NDRM

Jeff Yass’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Jeff Yass’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,700
Closed -$338K – 10504
2017
Q3 		$338K Sell
8,700
-144,700
-94% -$5.32M ﹤0.01% 7204
2017
Q2 		$4.59M Buy
153,400
+33,300
+28% +$863K ﹤0.01% 2514
2017
Q1 		$3.19M Buy
+120,100
New +$2.98M ﹤0.01% 2938
2015
Q4 		– Sell
-57,900
Closed -$1.2M – 10662
2015
Q3 		$1.2M Buy
+57,900
New +$1.19M ﹤0.01% 5323

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Jeff Yass's NDRM Position: Q2 2017 in Review

Jeff Yass sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2017, closing a stake of 31,765 shares — an estimated $823K sold.

Jeff Yass first reported a position in NDRM in Q1 2017 and held it in 1 quarter. The position peaked at $843K in Q1 2017. 73 funds tracked by Wall St. Rank hold NDRM as of Q2 2017.

  • Jeff Yass reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • Jeff Yass sold 31,765 NeuroDerm Ltd. Ordinary Shares shares in Q2 2017, an estimated $823K.
  • Jeff Yass first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2017 and held it in 1 quarter.
  • Jeff Yass's NeuroDerm Ltd. Ordinary Shares position peaked at $843K in Q1 2017.
  • 73 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2017.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.